204-235-3206 info@sbrc.ca
Select Page
Albensi paper suggests how Covid-related neurological symptoms such as headaches, coma and brain-fog could be treated with therapeutics targeting pathways prone to inflammation.

Albensi paper suggests how Covid-related neurological symptoms such as headaches, coma and brain-fog could be treated with therapeutics targeting pathways prone to inflammation.

by | Jun 3, 2021 | DND News, Home News

The paper titled: The Effect of COVID-19 on NF-κB and Neurological Manifestations of Disease was published today in a special issue on COVID-19, in Molecular Neurobiology, and shows how therapeutics that reduce the NF-κB pathway should be considered in the treatment...
Study warns of significant dementia increase

Study warns of significant dementia increase

by | Jul 4, 2018 | DND News, Home News

The number of Manitobans living and affected by dementia is projected to dramatically increase, according to a study recently published in Neuroepidemiology (Karger). The largest increase is projected to occur in the 75–84 years of age group with a growth of 98.83% by...
Glazner featured in FP article on Meth

Glazner featured in FP article on Meth

by | Mar 12, 2018 | DND News, Home News

Dr. Gordon Glazner, Principal Investigator, Cellular Neuropathology & Neurodegeneration, Division of Neurodegenerative Disorders, was featured in the Winnipeg Free Press this past weekend in a full-page article on the destructive effects of methamphetamine on the...